G. Defer

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease

Rose Marie, Louisa Barré, B. Dupuy et al. · Neuroscience Letters · 1999 · 176 citations

Striatal Dopamine Denervation, Frontal Executive Tests, Brain Function +5

Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease

Anne‐Catherine Bachoud‐Lévi, Catherine Bourdet, Pierre Brugières et al. · Experimental Neurology · 2000 · 158 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Neurological Disorder +9

High‐dose transdermal nicotine in Parkinson's disease patients: a randomized, open‐label, blinded‐endpoint evaluation phase 2 study

Gabriel Villafane, Claire Thiriez, Étienne Audureau et al. · European Journal of Neurology · 2017 · 86 citations

Paraneoplastic Cerebellar Syndrome and Optic Neuritis With Anti-CV2 Antibodies

Vincent de La Sayette, Françoise Bertran, Jérôme Honnorat et al. · Archives of Neurology · 1998 · 77 citations